Attached files
file | filename |
---|---|
10-K - 10-K - aTYR PHARMA INC | life-10k_20151231.htm |
EX-32.2 - EX-32.2 - aTYR PHARMA INC | life-ex322_8.htm |
EX-32.1 - EX-32.1 - aTYR PHARMA INC | life-ex321_9.htm |
EX-31.2 - EX-31.2 - aTYR PHARMA INC | life-ex312_10.htm |
EX-31.1 - EX-31.1 - aTYR PHARMA INC | life-ex311_11.htm |
EX-10.3 - EX-10.3 - aTYR PHARMA INC | life-ex103_474.htm |
EX-10.18 - EX-10.18 - aTYR PHARMA INC | life-ex1018_655.htm |
EX-10.16 - EX-10.16 - aTYR PHARMA INC | life-ex1016_653.htm |
EX-10.17 - EX-10.17 - aTYR PHARMA INC | life-ex1017_1072.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm (EY to provide changes)
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-203955) of aTyr Pharma Inc. and in the related Prospectus of our report dated May 6, 2015, with respect to the financial statements of aTyr Pharma Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst & Young LLP
San Diego, California
March 30, 2016